Neurocrine Biosciences Inc (NBIX)
135.92
-1.84
(-1.34%)
USD |
NASDAQ |
Apr 26, 16:00
135.92
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Revenue (TTM): 1.887B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.887B |
| September 30, 2023 | 1.784B |
| June 30, 2023 | 1.673B |
| March 31, 2023 | 1.598B |
| December 31, 2022 | 1.489B |
| September 30, 2022 | 1.389B |
| June 30, 2022 | 1.297B |
| March 31, 2022 | 1.208B |
| December 31, 2021 | 1.134B |
| September 30, 2021 | 1.069B |
| June 30, 2021 | 1.032B |
| March 31, 2021 | 1.045B |
| December 31, 2020 | 1.046B |
| September 30, 2020 | 1.042B |
| June 30, 2020 | 1.006B |
| March 31, 2020 | 886.80M |
| December 31, 2019 | 788.10M |
| September 30, 2019 | 675.45M |
| June 30, 2019 | 605.11M |
| March 31, 2019 | 518.51M |
| December 31, 2018 | 451.20M |
| September 30, 2018 | 414.26M |
| June 30, 2018 | 323.28M |
| March 31, 2018 | 232.71M |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 2.919M |
| September 30, 2013 | 24.14M |
| June 30, 2013 | 32.76M |
| March 31, 2013 | 42.60M |
| December 31, 2012 | 53.14M |
| September 30, 2012 | 42.30M |
| June 30, 2012 | 74.58M |
| March 31, 2012 | 76.17M |
| December 31, 2011 | 77.41M |
| September 30, 2011 | 79.96M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
605.11M
Minimum
Jun 2019
1.887B
Maximum
Dec 2023
1.192B
Average
1.069B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Globus Medical Inc | 1.568B |
| Inspire Medical Systems Inc | 624.80M |
| AIM ImmunoTech Inc | 0.202M |
| Protalix BioTherapeutics Inc | 65.49M |
| Armata Pharmaceuticals Inc | -- |